Middle East and Africa Lab Diagnostics Market, By Solution (Product Type and Test Type), Test Type (Clinical Chemistry and Immunoassays, Infectious Disease Testing, Microbiology, Mycology and Parasitology, Haematology, POCT, Human Chorionic Gonadotropin (HCG), and Others), Product Type (Reagents & Consumables, Analysers & Instruments, and Accessories), Sample Type (Blood, Urine, Sputum, Tissue, and Others), Therapeutic Area (Metabolic Disorders, Infections, Oncology, Genetic Disorders, Urology, Gynaecology, and Others), End User (Hospital-Based Labs, Stand-Alone Labs, Diagnostic Chains, and Others), Distribution Channel (Direct Tender, Retail Sales, and Third Party Distributor) – Industry Trends and Forecast to 2030.
Middle East and Africa Lab Diagnostics Market Analysis and Size
Growing awareness associated with early diagnosis has increased the demand for lab diagnostics in MEA. The diabetes segment is anticipated to witness healthy growth during the forecast period. The introduction of varied new technologies and increasing penetration of private independent laboratories have led to substantial progress in the clinical laboratory segment in the UAE and Saudi Arabia.
Data Bridge Market Research analyses a growth rate in the Middle East and Africa lab diagnostics market in the forecast period 2023-2030. The expected CAGR of the Middle East and Africa lab diagnostics market tends to be around 5.60% in the mentioned forecast period. The market was valued at USD 5,282.63 million in 2022 and would grow to USD 8,168.87 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Lab Diagnostics Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Solution (Product Type and Test Type), Test Type (Clinical Chemistry and Immunoassays, Infectious Disease Testing, Microbiology, Mycology and Parasitology, Haematology, POCT, Human Chorionic Gonadotropin (HCG), and Others), Product Type (Reagents & Consumables, Analysers & Instruments, and Accessories), Sample Type (Blood, Urine, Sputum, Tissue, and Others), Therapeutic Area (Metabolic Disorders, Infections, Oncology, Genetic Disorders, Urology, Gynaecology, and Others), End User (Hospital-Based Labs, Stand-Alone Labs, Diagnostic Chains, and Others), Distribution Channel (Direct Tender, Retail Sales, and Third Party Distributor)
|
|
Countries Covered
|
Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd (Switzerland), Abbott. (U.S.), B.D. (U.S.), COSMED srl (Italy), Thermo Fisher Scientific Inc. (U.S.), Carestream Health (U.S.), VYAIRE (U.S.), Siemens Healthineers AG (Germany), Quidel Corporation (U.S.), Danaher (U.S.), Trinity Biotech (Ireland), PTS Diagnostics (U.S.), Sekisui Diagnostics (U.S.), Thermo Fisher Scientific Inc. (U.S.), BIOMÉRIEUX (France)
|
|
Market Opportunities
|
|
Market Definition
Laboratory tests and diagnostic procedures are tests done to check a person's normal vitals and abnormalities. The laboratory tests are generally done using the patient's blood, saliva, urine, or tissue samples, and skilled laboratory technicians will examine the results obtained within the normal range. It involves processes such as spirometry, oximetry, chest X-ray, computed tomography, and transcutaneous carbon dioxide monitoring, among several other types.
Middle East and Africa Lab Diagnostics Market Dynamics
Drivers
- Introduction of Advanced Technologies
Varied introductions of new technologies and increasing penetration of private independent laboratories have led to major progress in the clinical laboratory segment in the UAE and Saudi Arabia. Therefore, there has been an increasing shift towards independent labs from hospital-based laboratories with technological advancements. Many such developments are most likely to increase market growth. In 2022, AACC partnered with Life Diagnostics to relaunch AACC Middle East. The two-day conference and exposition would showcase world-class in-vitro diagnostic innovations and clinical laboratory best practices in Dubai, UAE. Also, Thermo Fisher provides an A.B. Assurance Dx service plan specifically for IVD instruments; the plan is devised to maintain instrument performance and ensure the availability of important instrument systems in the workflow. Thus, this factor boosts the market growth
Opportunities
- Higher Demand for Hospitals
The increasing demand for hospitals helps in growing the market grows rapidly. Most lab disease diagnostics are mainly carried out in hospitals as they are slightly complex and need technologically advanced products; thus, this is boosting the market for hospital or clinical laboratories. Thus, this factor boosts market growth.
- Increasing Use of In-vitro Diagnostics (IVD) and Point of Care Testing (POCT)
In-vitro diagnostics (IVD) and point-of-care testing (POCT) are anticipated to witness huge growth. There has been huge growth in demand for economical, rapid, easy-to-use POCT devices for infectious disease diagnostics in the UAE. Such extensive developments are likely to enhance the market. Other important areas with major growth opportunities include smart labs-as-a-service for the automation of laboratory services, the adoption of managed clinical services in the area's hospitals, and the need for next-generation sequencing testing for genetic testing. Thus, this factor boosts market growth.
Restraints/Challenges
- High Cost of Diagnostic Instruments
The increased cost required for installing these instruments impedes the market growth. Many diagnostic types of equipment are very expensive, becoming unaffordable for many developing countries. Several market players make large investments in installing new and advanced machines to surge the process, and in return, the cost is increased. Thus, this factor hampers the market growth.
This Middle East and Africa lab diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa lab diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Middle East and Africa Lab Diagnostics Market Scope
The Middle East and Africa lab diagnostics market is segmented on the basis of solution, test type, product type, sample type, therapeutic area, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Solution
- Product Type
- Test Type
Test Type
- Clinical Chemistry and Immunoassays
- Infectious Disease Testing
- Microbiology
- Mycology and Parasitology
- Haematology
- POCT
- Human Chorionic Gonadotropin (HCG)
- Others
Product Type
- Reagents & Consumables
- Analysers & Instruments,
- Accessories
Sample Type
- Blood
- Urine
- Sputum
- Tissue
- Others
Therapeutic Area
- Metabolic Disorders
- Infections
- Oncology
- Genetic Disorders
- Urology
- Gynaecology
- Others
End User
- Hospital-Based Labs
- Stand-Alone Labs
- Diagnostic Chains
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Other
Middle East and Africa Lab Diagnostics Market Regional Analysis/Insights
The Middle East and Africa lab diagnostics market is analysed and market size insights and trends are provided by solution, test type, product type, sample type, therapeutic area, end user and distribution channel as referenced above.
The major countries covered in the bone marrow biopsy market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
South Africa is anticipated to lead the market due to the wide presence of the largest consumer market. The increase in technological advancement and chronic diseases, awareness associated with early diagnosis, and demand for lab diagnostics, among other factors, boost the market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The lab diagnostics also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for lab diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the lab diagnostics market. The data is available for historic period 2011-2021.
Competitive Landscape and Middle East and Africa Lab Diagnostics Market Share Analysis
The Middle East and Africa lab diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Middle East and Africa lab diagnostics market
Key players operating in the Middle East and Africa lab diagnostics market include:
- F. Hoffmann-La Roche Ltd (Switzerland)
- Abbott.(U.S.)
- BD (U.S.)
- COSMED srl (Italy)
- Thermo Fisher Scientific Inc. (U.S.)
- Carestream Health (U.S.)
- VYAIRE (U.S.),
- Siemens Healthineers AG (Germany)
- Quidel Corporation (U.S.)
- Danaher (U.S.)
- Trinity Biotech (Ireland)
- PTS Diagnostics (U.S.)
- Sekisui Diagnostics (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- BIOMÉRIEUX (France)
SKU-